Quelque chose à améliorer ? Proposez une modification.
Multisystem inflammatory syndrome in children (MIS-C) is a rare but serious condition that usually appears 2–6 weeks after a SARS-CoV-2 infection, with fever and inflammation affecting several organs. CDC began national surveillance in May 2020, with state and local health departments reporting cases voluntarily; a new case definition, written with the Council of State and Territorial Epidemiologists (CSTE), took effect on January 1, 2023 (about 87% of cases under the old definition also meet the new one).

Image from CDC's report
Far fewer cases — but not none
| Period | MIS-C incidence (per million person-months) |
|---|---|
| Peak: October 2020–April 2021 | 6.79 |
| April–December 2022 | 0.56 |
| 2023 | 0.11 — down 80% from 2022 and 98% from the peak |
117 children and young people had MIS-C starting in 2023. After COVID-19 rose in early summer, 31 cases (26%) began in August–October — about two-thirds more than the 19 in the three months before.
Who got sick
| 117 patients, 2023 | |
|---|---|
| Median age | 6.9 |
| Aged 5–11 | 50 (42.7%) |
| Aged 1–4 | 34 (29.1%) |
| Male | 72 (61.5%) |
| No underlying condition | 68 (58%) |
| Obesity | 32 (27.4%) |
| Chronic lung disease, including asthma | 16 (13.7%) |
| Lived in the South | 55 (47.0%) |
How sick they were
| 2023 | Jul 2021–Jan 2022 (2,116 cases) | Feb 2020–Jul 2021 (4,470 cases) | |
|---|---|---|---|
| Needed ICU-level care | 50% | 52% | 63% |
| Shock | 34% | 38% | 45% |
| Cardiac dysfunction | 27% | 29% | 31% |
Three patients (3%) died in 2023. Most patients had gastrointestinal (88.9%) and skin or mucous-membrane (88.9%) involvement, and more than half had heart (53.8%) or blood (53.8%) involvement. Most were treated with intravenous immunoglobulin (85.5%) and steroids (80.3%); the median hospital stay was 4 days.
Vaccination
Of the 112 patients old enough to be vaccinated:
- 92 (82.1%) had no COVID-19 vaccine;
- only 20 (18%) had any dose — and 12 of those 20 (60%) had their last dose more than 12 months before falling ill, so their protection had likely waned;
- among the 48 eligible patients with an underlying condition, just 9 (19%) were vaccinated.
What it means
- MIS-C is still happening, if far less often — and the 2023 figures are probably an undercount, since reporting is incomplete and the case definition changed that year. The drop may also reflect immunity from vaccination and past infection and the traits of the variants now circulating.
- Cases have shifted toward younger children, and the illness's features have changed.
- Clinicians should keep MIS-C in mind, especially during and after COVID-19 surges, and know the treatment guidelines.
- Keep reporting cases to health departments.
- CDC recommends that everyone 6 months and older stay up to date with COVID-19 vaccination, to protect against severe illness and complications including MIS-C.
Sources
Based on Anna R. Yousaf, Katherine N. Lindsey, Michael J. Wu, Ami B. Shah, Rebecca J. Free, Regina M. Simeone, Laura D. Zambrano, Angela P. Campbell and the MIS-C Surveillance Authorship Group, "Notes from the Field: Surveillance for Multisystem Inflammatory Syndrome in Children — United States, 2023," MMWR, volume 73, Centers for Disease Control and Prevention; a work of the United States government in the public domain.
Licence : CC0 1.0 (domaine public) · Adapté de www.cdc.gov
1
0
0
0

commentaires






